Immunis’ Treats its First Patients for Sarcopenic Obesity
Immunis, Inc., a clinical-stage biotech developing multi-active biologics for age and disease-related immune dysregulation, ...
Adial Pharmaceuticals Reports 2024 Fiscal Year Financial Results and Provides Business Update
On November 5, 2024, Adial announced the appointment of Vinay Shah as the Company’s Chief Financial Officer. Mr. Shah is an accomplished Chief Financial Officer with over 25 years of experience in the ...
Health Affairs53m
Podcast: Jihye Han Compares First-In-Class Drug Regulation in the US and Europe
Health Affairs' Senior Deputy Editor Rob Lott interviews Jihye Han of Brigham and Women's Hospital and Harvard University on ...